Christopher Howard Biography and Net Worth

EVP of Acadia Healthcare

Christopher L. Howard serves as Executive Vice President, General Counsel, Secretary of the Company. Christopher L. Howard joined the Company in February 2011 and has served as our Executive Vice President, General Counsel and Secretary since that time. Before joining the Company, Mr. Howard served as PSI’s Executive Vice President, General Counsel and Secretary from September 2005 to November 2010. Prior to joining PSI, Mr. Howard was a partner at Waller Lansden Dortch & Davis, LLP, a law firm based in Nashville, Tennessee.

What is Christopher L. Howard's net worth?: The estimated net worth of Christopher L. Howard is at least $10.62 million as of August 8th, 2022. Mr. Howard owns 149,147 shares of Acadia Healthcare stock worth more than $10,617,775 as of April 25th. This net worth approximation does not reflect any other assets that Mr. Howard may own. Learn More about Christopher L. Howard's net worth.
How do I contact Christopher L. Howard?: The corporate mailing address for Mr. Howard and other Acadia Healthcare executives is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. Acadia Healthcare can also be reached via phone at (615) 861-6000. Learn More on Christopher L. Howard's contact information.
Has Christopher L. Howard been buying or selling shares of Acadia Healthcare?: Christopher L. Howard has not been actively trading shares of Acadia Healthcare during the last ninety days. Most recently, Christopher L. Howard sold 12,214 shares of the business's stock in a transaction on Monday, August 8th. The shares were sold at an average price of $81.67, for a transaction totalling $997,517.38. Following the completion of the sale, the executive vice president now directly owns 149,147 shares of the company's stock, valued at $12,180,835.49. Learn More on Christopher L. Howard's trading history.
Who are Acadia Healthcare's active insiders?: Acadia Healthcare's insider roster includes David Duckworth (CFO), William Grieco (Director), John Hollinsworth (EVP), Christopher Howard (EVP), Debra Osteen (Director), William Petrie (Director), and Reeve Waud (Director). Learn More on Acadia Healthcare's active insiders.
Are insiders buying or selling shares of Acadia Healthcare?: In the last year, insiders at the sold shares 6 times. They sold a total of 150,203 shares worth more than $11,148,279.17. The most recent insider tranaction occured on March, 5th when Director Wade D Miquelon sold 2,203 shares worth more than $188,114.17. Insiders at Acadia Healthcare own 2.8% of the company. Learn More about insider trades at Acadia Healthcare.
Information on this page was last updated on 3/5/2024.

Christopher L. Howard Insider Trading History at Acadia Healthcare

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/8/2022	Sell	12,214	$81.67	$997,517.38	149,147
8/22/2017	Sell	53,713	$50.69	$2,722,711.97	147,286
8/3/2017	Sell	16,762	$52.47	$879,502.14	200,999
2/18/2015	Sell	9,378	$62.75	$588,469.50
11/3/2014	Sell	29,245	$59.94	$1,752,945.30
7/29/2014	Sell	1,156	$51.01	$58,967.56
12/24/2012	Sell	8,774	$21.60	$189,518.40

Christopher L. Howard Buying and Selling Activity at Acadia Healthcare

Acadia Healthcare Company Overview

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Today's Range

Now: $71.19

$70.46

$71.36

50 Day Range

MA: $78.68

$70.16

$87.38

2 Week Range

Now: $71.19

$66.49

$87.77

Volume

454,423 shs

Average Volume

560,294 shs

Market Capitalization

$6.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…